2008-06-09 23:57:32 -
- Media: Hewes Communications, Inc. Tucker Hewes, 212-207-9451 tucker@hewescomm.com Needham & Company, LLC will hold its Seventh Annual Biotechnology & Medical Technology Conference at the New York Palace Hotel on June 11 and 12. Over 100 leading biotechnology and medical technology companies are scheduled to present.
"Given Needham's focus on growth stocks, we will feature some of the most
interesting small and mid-cap biotech companies along with a select group of large cap companies at our Seventh Annual Conference," said Dr. Mark Monane, Managing Director, Equity Research, Biotechnology and Life Sciences at Needham & Company. "Our eight 'Meet the Expert' sessions will provide attendees with up-to-date information from academic clinicians and researchers. In addition, since the conference will once again come on the heels of the American Society of Clinical Oncology (ASCO) Annual Meeting, it will serve as a platform to analyze and discuss the information coming out of that event."
Some of the topics that attending companies will cover are:
-- Pain: A geriatric medical issue
-- Cancer: Breakthroughs in prostate and brain cancers
-- Obesity: Using natural hormones to reduce the desire to eat
-- Infectious Diseases: New approaches in treating the Hepatitis C epidemic
-- Medical Tech: Hardware to go along with medical options
-- Diagnostics: Tackling women's health issues
-- Heart Disease: Options for prevention and treatment of cardiac diseases
In addition to company presentations, there will be several special "Meet the Expert" discussions: -0- Wednesday, June 11: 4:00 pm Emerging Themes & Therapies in Cancer Care 4:00 pm Hepatitis C: Update on Therapeutics Under Development Thursday, June 12: 8:00 am Cardiology 2008 - Storm Clouds Approaching or All Calm Ahead? 8:00 am Emerging Technologies in Body Shaping and Cellulite Treatment Update on the Development of Therapeutic Options in 12:00 pm Alzheimer's Disease Reimbursement Impact on Medical Technologies: A Washington 12:00 pm Perspective 4:00 pm Emerging Treatment Options for Obesity 4:00 pm Spine Devices
The conference is open to clients of Needham & Company, LLC by invitation only. For more information, call (800) 926-2765. About Needham & Company, LLC
Needham & Company, LLC, a wholly owned subsidiary of The Needham Group, Inc., is a privately held, full-service investment bank with the mission of helping emerging growth companies achieve their potential. The firm is headquartered in New York City with offices in Boston, Menlo Park and San Francisco. In addition to investment banking, Needham's principal activities include institutional sales and trading, and asset management. To serve its institutional clients, Needham & Company, LLC produces comprehensive equity research on more than 350 companies in technology, health care, consumer and industrial growth. Needham & Company, LLC is a member of FINRA/SIPC. More information is available at www.needhamco.com.
Largest Conference for Small and Mid-Cap Biotechnology and Medical
Technology Companies
